Abstract
Studies by Qu et al in this issue of Blood provide new mechanistic insight into the ineffective erythropoiesis of TET2 deficiency including selective colony-forming unit–erythroid (CFU-E) hyperproliferation, heightened expression of KIT and AXL, and the rescue by KIT and AXL inhibitors of faltered late stage erythropoiesis.